P Haegèle

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

Thierry Petit, M. Wilt, Michel Velten et al. · European Journal of Cancer · 2003 · 273 citations

Medicine, Oncology, Pharmacology +17

Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous-cell carcinoma

Thomas Petit, Claire Georges, G.-M. Jung et al. · Annals of Oncology · 2001 · 79 citations · Full text

Medicine, Oncology, Cancer Screening +11

Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting.

Thierry Petit, Christian Borel, J.P. Ghnassia et al. · PubMed · 2001 · 77 citations

Medicine, Oncology, Pharmacology +15

Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: Final results of a controlled clinical trial

A Roussel, Harry Bleiberg, O. Dalesio et al. · International Journal of Radiation Oncology*Biology*Physics · 1989 · 49 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus

Th. Wobbes, B. Barón, B Paillot et al. · European Journal of Cancer · 2001 · 48 citations

Medicine, Oncology, Radiation Oncology +10